| __timestamp | Cytokinetics, Incorporated | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 44426000 | 176081000 |
| Thursday, January 1, 2015 | 46398000 | 157939000 |
| Friday, January 1, 2016 | 59897000 | 164073000 |
| Sunday, January 1, 2017 | 90296000 | 169243000 |
| Monday, January 1, 2018 | 89135000 | 168489000 |
| Tuesday, January 1, 2019 | 86125000 | 172526000 |
| Wednesday, January 1, 2020 | 96951000 | 200649000 |
| Friday, January 1, 2021 | 159938000 | 237513000 |
| Saturday, January 1, 2022 | 240813000 | 353358000 |
| Sunday, January 1, 2023 | 330123000 | 586886000 |
Unleashing the power of data
In the competitive landscape of the biopharmaceutical industry, understanding cost efficiency is crucial. Lantheus Holdings, Inc. and Cytokinetics, Incorporated, two prominent players, have shown distinct trajectories in their cost of revenue from 2014 to 2023.
Lantheus has consistently maintained a higher cost of revenue, peaking at approximately 587% of its 2014 value by 2023. This growth reflects their aggressive expansion and investment in production capabilities.
Cytokinetics, on the other hand, has seen a more gradual increase, with their cost of revenue growing to about 743% of its 2014 value by 2023. This indicates a strategic focus on optimizing production processes and cost management.
The data highlights the contrasting strategies of these companies, offering insights into their operational efficiencies and market positioning over the past decade.
Cost of Revenue: Key Insights for AbbVie Inc. and Lantheus Holdings, Inc.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Cytokinetics, Incorporated
Cost Insights: Breaking Down Zoetis Inc. and Cytokinetics, Incorporated's Expenses
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc.
Comparing Cost of Revenue Efficiency: Jazz Pharmaceuticals plc vs Cytokinetics, Incorporated
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Grifols, S.A.
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Cytokinetics, Incorporated
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Geron Corporation
Comparing Cost of Revenue Efficiency: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Telix Pharmaceuticals Limited
Analyzing Cost of Revenue: Cytokinetics, Incorporated and CRISPR Therapeutics AG
Cost of Revenue Comparison: Cytokinetics, Incorporated vs MiMedx Group, Inc.